NCT00988312View on ClinicalTrials.gov

Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

February 29, 2004

Study Completion Date

March 31, 2004

Conditions
Multiple MyelomaPlasmocytoma
Interventions
BIOLOGICAL

autologous idiotype-protein pulsed dendritic cells

Vaccination with autologous idiotype-protein pulsed dendritic cells on 5 occasions every 4 weeks

Trial Locations (1)

01307

University Hospital Dresden, Dresden

All Listed Sponsors
lead

University Hospital Carl Gustav Carus

OTHER

NCT00988312 - Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma | Biotech Hunter | Biotech Hunter